Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citigroup Inc. (C) vs Merck & Co., Inc. (MRK) Price & Performance

Citigroup Inc.Trade
Merck & Co., Inc.Trade

Price performance (Past 24H)

Key statistics

Citigroup Inc. vs Merck & Co., Inc. — how do they compare? Citigroup Inc. trades at $135.82 (market cap $226.82B), while Merck & Co., Inc. trades at $130.23 (market cap $323.00B). The key difference: Merck & Co., Inc. is the larger of the two by market cap, and Merck & Co., Inc. pays the higher dividend (2.6%). Which is the better fit depends on your goals.

CMRK
Market Cap
$226.82B$323.00B
Sector
FinancialsHealth
52-Week High
$145.67$131.84
52-Week Low
$92.59$77.60
Dividend Yield
1.98%2.6%
Enterprise Value
$369.77B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Citigroup Inc.

No Aura AI signal available yet.

Merck & Co., Inc.

Merck (MRK) trades at $130.90, up 1.81% on the day, with a bullish technical outlook and strong institutional support. Recent earnings beats in Q4 2025 and Q1-Q2 2026, alongside a 28.07% net income margin in 2025, highlight operational strength. The acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline, though a high P/E of 104.74 signals premium valuation. Cash flow remains positive at $1.37B in 2025, but investing outflows have increased.

The stock offers growth potential from pipeline expansion and analyst consensus targeting $140.36, but risks include elevated debt-to-asset ratios (36.06% in 2025) and competitive pressures. Investors should weigh robust profitability against valuation concerns and macroeconomic headwinds affecting the pharma sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Citigroup Inc.

Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.

Read more on C

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

Read more on MRK